Tricyclic compounds useful as angiotensin ii agonists
CA 2449150 C · Owner: Vicore Pharma Ab · Inventors: Hallberg, Anders; Alterman, Mathias
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
There is provided compounds of formula (I) wherein X1, X2, X3, X4, Y1, Y2, Y3, Y4 Z1, Z2, R4 and R5 have meanings given in the description and , pharmaceutically-acceptable salts thereof which compounds are useful as , selective agonists of the AT2 receptor and thus, in particular, in the , treatment of inter alia gastrointestinal conditions such as dyspepsia, IBS , and MOF, and cardiovascular disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 30, 2002 and granted July 12, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 30, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 30, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.